ArticleJournal of neuroengineering and rehabilitation2026
Multimodal machine learning mobility assessment in Parkinson's disease within supervised and unsupervised settings.
Article in Journal of neuroengineering and rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Surface Electromyography for Parkinson's Disease Monitoring: A Review of Machine and Deep Learning Techniques.Sensors (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMobility in people with Parkinson’s disease (PwPD) is strongly context-dependent. Clinic-based assessments provide only brief snapshots under controlled conditions and may not reflect everyday functional capacity. Wearable sensors enable continuous free-living monitoring, yet most studies use unimodal signals and simple threshold-based walking detection. Multimodal sensing, combining surface electromyography (sEMG) with inertial measurement units (IMUs), can offer a more complete picture of mobility in Parkinson’s disease (PD). Therefore, developing a data-driven multimodal gait analysis pipeline is essential for accurately identifying walking episodes and deriving detailed gait characteristics of PD in unsupervised free-living settings.
methodsTen PwPD wore four thigh and shank sensors (IMU + sEMG) during supervised laboratory and outdoor walks, followed by unsupervised free-living recording on the same day. Video captured using eye-tracking glasses was used to annotate the supervised data, which were then used to train a machine learning (ML) model based on IMU-only and fused IMU + sEMG features. The trained model was applied to the unsupervised data to detect walking bouts, after which spatiotemporal, kinematic, and muscle-activation measures were computed.
resultsWalking-bout detection using IMU features alone achieved acceptable performance (F1 = 87.53%), with higher performance observed when sEMG features were included (F1 = 94.45%). Exploratory analyses suggested that unsupervised walking may be associated with slower pace, greater variability, and increased asymmetry compared with supervised walking. A reduction in knee flexion-extension (F-E) amplitude and an earlier occurrence of peak F-E were also observed during unsupervised walking. Additionally, higher lower-limb muscle activation during stance was noted, indicating potentially increased neuromuscular demand in free-living conditions. These findings should be interpreted cautiously and are intended to be hypothesis-generating rather than definitive.
conclusionThis pilot study successfully presents a multimodal, data-driven framework integrating neuromuscular and kinematic signals to assess mobility in supervised and unsupervised settings. The analysis of combined changes in muscle activation, joint kinematics, and spatiotemporal gait measures reveals interconnected gait adaptations that are otherwise missed by unimodal systems. These findings suggest the potential for novel. multimodal digital biomarkers that offer an ecologically valid, continuous monitoring of motor function in PwPD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.